
Argenx sees unusual setback with failure of late-stage study of drug for autoimmune disease
<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxOdElDMHVUa0gzVThrS3lHYmNQZTB5V2x1RFJRR0tCbnR6R3BHVHNZOFcyT0dOcGlnb3hUQ0FWWS10bkNsLVlxQlNtQWp2N3NwZ0ZjSU1iUE9HWXlYeHJjVGh3VE5jcER6RnJ3a2lLMHBsT2tyYjB1R3BLeUxmUnJRRXpsbw?oc=5" target="_blank">Argenx sees unusual setback with failure of late-stage study of drug for autoimmune disease</a>&nbsp;&nbsp;<font color="#6f6f6f">STAT</font>
